| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Sep―09 |
COVID-19 in Autoimmune Rheumatic Diseases: Lessons Learned and Emerging Risk Stratification Approaches |
Vasiliki E. Georgakopoulou, Clio P. Mavragani |
| 2 |
[GO] |
2025―Jan―08 |
Human Leukocyte Antigen (HLA) at the Root of Persistent Antigens and Long COVID |
Apostolos Georgopoulos, Lisa James, Phillip Peterson |
| 3 |
[GO] |
2024―Jul―23 |
Advances in Understanding the Envelope Protein in Coronavirus Infection |
Aakanksha Agarwal, Ashley L. Steed |
| 4 |
[GO] |
2023―Feb―21 |
Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes |
Ada Alice Dona, James F Sanchez, Joycelynne M Palmer, Timothy W. Synold, Flavia Chiuppesi, Sandra Thomas, Enrico Caserta, Mahmoud Singer, Theophilus Tandoh, Arnab Chowdhury, Amrita Krishnan, Michael Rosenzweig, Don J Diamond, Steven Rosen, Flavia Pichiorri, Sanjeet Dadwal |
| 5 |
[GO] |
2022―Oct―04 |
Serologic Response of SARS-CoV-2 mRNA-based Vaccines in Patients with Autoimmune Diseases |
Kushal Gandhi, Nathan Joshua Manales, Asley Sanchez, Srikanth Mukkera, Anusha Ammu, Janine Klar, Alex Gibson, Evangelina Santiago, Ailena Mulkey, Jammie Holland, Maneesh Mannem, Lakshmi P. Alahari, John Garza |
| 6 |
[GO] |
2022―Jun―29 |
Bispecific Antibodies as an Alternative to Antibody Cocktails for SARS-CoV-2: A Mini- Review |
Gavin Yuen, Saundarai Bhanot, Jeremy Steen, Minahil Syed, Austin Mardon |
| 7 |
[GO] |
2021―Dec―28 |
Epitope-based Multi-variant SARS-Cov-2 Vaccine Design: Shared Epitopes Among the Natural SARS-Cov-2 Spike Glycoprotein and 5 of its Variants (D614G, α, β, γ, δ) with High in Silico Binding Affinity to Human Leukocyte Antigen (HLA) Class II Molecules |
Spyros A. Charonis, Apostolos P. Georgopoulos |
| 8 |
[GO] |
2021―Oct―22 |
Coenzyme Q10 and Vitamin D Interventions Could Ameliorate COVID-19 Related Cellular Bioenergetic Dysfunction and Cytokine Storms |
Darshna Yagnik |
| 9 |
[GO] |
2021―May―07 |
SARS-CoV-2: Insights from the Immunopathogenesis and Current Clinical Diagnosis and Therapeutic Strategies |
Shruti Sharma, Ujjawal Sharma, Anupama Chaudhary, Manisha Naithani, Priyanka x Priyanka Naithani, Saurabh Prashar, Bunty Sharma, Pramod Kumar Nagar, Prudhvi Lal Bhukya, Unnati B halerao, Meenakshi Singh, Manjita Srivastava, Muneesh Kumar Barman, Sampan Attri, Jitender Gairolla |
| 10 |
[GO] |
2021―Apr―07 |
Commentary: Role of Tocilizumab in Hospitalized COVID-19 Patients: A Pragmatic Guide for Clinicians |
Vijairam Selvaraj, Anneliese Beaubrun, Shenjun Zhu, Kwame Dapaah-Afriyie |
| 11 |
[GO] |
2021―Feb―11 |
Commentary: COVID-19 and the Path to Immunity |
Lisa James, Effie-Photini Tsilibary, Spyros Charonis, Apostolos Georgopoulos |
| 12 |
[GO] |
2021―Feb―11 |
SARS-CoV-2 Virus and Human Leukocyte Antigen (HLA) Class II: Investigation in silico of Binding Affinities for COVID-19 Protection and Vaccine Development |
Spyros Charonis, Effie-Photini Tsilibary, Apostolos Georgopoulos |
| 13 |
[GO] |
2021―Feb―11 |
Heterologous Protection to COVID-19 with BCG Vaccine: Deciphering the Reality Using Meta-Analysis Approach |
Anurag Singh, Lakshya Gupta, Vandana Gupta |
| 14 |
[GO] |
2020―Oct―29 |
Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19) |
Chandreyee Datta, Ashish Bhattacharjee |
| 15 |
[GO] |
2020―Oct―21 |
Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19) |
Chandreyee Datta, Ashish Bhattacharjee |
| 16 |
[GO] |
2020―Sep―15 |
SARS-CoV-2 Subversion of the Antiviral Interferon Alpha-Response of Lung Macrophages? |
Malgorzata Kloc, Rafik Ghobrial, Jacek Kubiak |
| 17 |
[GO] |
2020―Aug―13 |
Children Protection Against COVID-19 at the Pandemic Outbreak |
Dana Sabir, Nabaz Khwarahm, Shakhawan Ali, Hayman Abdoul, Kochar Mahmood, Rimantas Kodzius |
